首页 > 最新文献

Italian Journal of Pediatrics最新文献

英文 中文
Anorexia nervosa in children and adolescents: an early detection of risk factors. 儿童和青少年厌食症:早期发现风险因素。
IF 3.2 3区 医学 Q1 PEDIATRICS Pub Date : 2024-10-26 DOI: 10.1186/s13052-024-01796-6
Elena Bozzola, Sarah Barni, Maria Rosaria Marchili, Romie Hellmann, Emanuela Del Giudice, Giampaolo De Luca, Vita Cupertino

The incidence of eating disorders in children, mainly of anorexia nervosa, is dramatically increased in the last years. A timely identification of the disease is associated with higher rates of recovery. Aim of the work is to underline signs and symptoms that can be used to an early detection of anorexia nervosa in the pediatric age. A scoping review has been conducted by The Italian Pediatric Society Adolescent Study Group according to the PRISMA Extension guidelines for Scoping Reviews, using the search term "anorexia nervosa" and the following filters "review", "systematic review", "age 0-18", "last 4 years". The strategy search produced 657 studies, of which 52 were included in this revision. Screening and red flags were discussed in 23 reports, genetics in 12, neurological pathways in 11, environmental factors in 10, and gut microbiota in 7. An accurate physiological and pathological anamnesis, physical and psychological examination, including the body perception, should be taken in account as well as the presence of co-morbidities, including chronic functional abdominal pain and autoimmune/autoinflammatory diseases. Evidence suggests the role of familiar predisposition as well as of neurological morphology and pathway in anorexia nervosa development. Gut microbiota has also been included among possible risk factor for developing anorexia nervosa due to a complex direct and indirect interactions between gut and brain. The Italian Pediatric Society Adolescent Study Group suggests performing an accurate familial and personal anamnesis, including psychological evaluation as well as a physical exam including auxological parameters as a screening tool during pediatric checks to better explore the risk of developing anorexia nervosa.

近年来,儿童饮食失调症(主要是神经性厌食症)的发病率急剧上升。及时发现这种疾病与较高的康复率有关。这项工作旨在强调可用于早期发现儿童厌食症的体征和症状。意大利儿科学会青少年研究小组根据PRISMA扩展指南进行了范围界定研究,使用的检索词为 "神经性厌食症",筛选条件为 "综述"、"系统性综述"、"0-18岁"、"最近4年"。该策略检索产生了 657 项研究,其中 52 项被纳入本次修订。23 份报告讨论了筛查和红旗,12 份报告讨论了遗传学,11 份报告讨论了神经学途径,10 份报告讨论了环境因素,7 份报告讨论了肠道微生物群。准确的生理和病理病史、身体和心理检查(包括身体知觉)以及合并症(包括慢性功能性腹痛和自身免疫/自身炎症性疾病)的存在都应纳入考虑范围。有证据表明,神经性厌食症的形成与熟人倾向、神经系统形态和路径有关。由于肠道和大脑之间存在复杂的直接和间接相互作用,肠道微生物群也被列为神经性厌食症的可能风险因素之一。意大利儿科学会青少年研究小组建议,在儿科检查中进行准确的家庭和个人病史分析,包括心理评估以及包括辅助检查指标在内的体格检查,作为筛查工具,以更好地探索神经性厌食症的发病风险。
{"title":"Anorexia nervosa in children and adolescents: an early detection of risk factors.","authors":"Elena Bozzola, Sarah Barni, Maria Rosaria Marchili, Romie Hellmann, Emanuela Del Giudice, Giampaolo De Luca, Vita Cupertino","doi":"10.1186/s13052-024-01796-6","DOIUrl":"10.1186/s13052-024-01796-6","url":null,"abstract":"<p><p>The incidence of eating disorders in children, mainly of anorexia nervosa, is dramatically increased in the last years. A timely identification of the disease is associated with higher rates of recovery. Aim of the work is to underline signs and symptoms that can be used to an early detection of anorexia nervosa in the pediatric age. A scoping review has been conducted by The Italian Pediatric Society Adolescent Study Group according to the PRISMA Extension guidelines for Scoping Reviews, using the search term \"anorexia nervosa\" and the following filters \"review\", \"systematic review\", \"age 0-18\", \"last 4 years\". The strategy search produced 657 studies, of which 52 were included in this revision. Screening and red flags were discussed in 23 reports, genetics in 12, neurological pathways in 11, environmental factors in 10, and gut microbiota in 7. An accurate physiological and pathological anamnesis, physical and psychological examination, including the body perception, should be taken in account as well as the presence of co-morbidities, including chronic functional abdominal pain and autoimmune/autoinflammatory diseases. Evidence suggests the role of familiar predisposition as well as of neurological morphology and pathway in anorexia nervosa development. Gut microbiota has also been included among possible risk factor for developing anorexia nervosa due to a complex direct and indirect interactions between gut and brain. The Italian Pediatric Society Adolescent Study Group suggests performing an accurate familial and personal anamnesis, including psychological evaluation as well as a physical exam including auxological parameters as a screening tool during pediatric checks to better explore the risk of developing anorexia nervosa.</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"50 1","pages":"221"},"PeriodicalIF":3.2,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11515207/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Promotion of breastfeeding in Italian Maternity Hospitals: a pre-intervention study. 在意大利妇产医院推广母乳喂养:干预前研究。
IF 3.2 3区 医学 Q1 PEDIATRICS Pub Date : 2024-10-25 DOI: 10.1186/s13052-024-01793-9
Riccardo Davanzo, Guglielmo Salvatori, Mariella Baldassarre, Irene Cetin, Elsa Viora, Elena Scarpato

Background: In Italy, exclusive breastfeeding (EBF) rates at hospital discharge range unsatisfactorily between 20-97%.

Methods: In 2023, the Project for Hospital Policy on Breastfeeding (HPB) has been launched to promote breastfeeding in Italian Maternity Hospitals (MHs) as a joint initiative of the Italian Scientific Societies involved in perinatal care together with the National Midwife (FNOPO) and Nurse (FNOPI) Boards and with Vivere Onlus, a family association. The HBP Project has been designed as an uncontrolled before-after study to increase EBF rate at hospital discharge in the population of healthy, term infant with a normal weight at birth following an intervention bundle comprising: 1) Establishment of a local hospital Working Group; 2) Adoption of a hospital policy; 3) Implementation of breastfeeding monitoring; 4) Training for perinatal care professionals; 5) Enhanced implementation of the practices of skin-to-skin contact (SSC) and mother-baby rooming-in; 6) Development/Improvement of perinatal care protocols.

Results: We report the pre-intervention assessment of 89 out of the 111 enrolled MHs (80.2%) at the beginning of the Project (Time 1 or T1). Almost all MHs (96.6%) have a multi-professional Breastfeeding Working Group, while a hospital policy on breastfeeding is available only in 48.2%. Moreover, only 56.2% of the 9,777 perinatal health workers have been trained in breastfeeding. Over a 1-month period, SSC has been practiced in the delivery room by 76.9% of 6,304 term healthy newborn infants and rooming-in by 83.4% of 6,735 healthy term newborns of normal weight at birth. Over a 4-month period, 69.1% of 33,367 healthy term newborns of normal birth weight were exclusively breastfed at hospital discharge. Noticeably, EBF rate of MHs ranges from 4% up to 100%, the second quartile being 73%.

Conclusion: At T1 of the HPB Project, breastfeeding rates at hospital discharge for healthy, term infants with a normal weight at birth appear to be suboptimal among Italians MHs. Particularly, the range of EBF rates among participating centers is wide, with 50% of the MHs having EBF rate lower than 73%. Therefore, the ongoing HPB Project might represent not only an opportunity to increase the initiation of breastfeeding and to improve quality of health care in the whole study group of MHs, but possibly also to level differences between centers.

背景:在意大利,出院时纯母乳喂养率(EBF)介于 20-97% 之间,并不令人满意:2023 年,意大利围产期保健科学协会、国家助产士委员会(FNOPO)和护士委员会(FNOPI)以及家庭协会 Vivere Onlus 联合发起了医院母乳喂养政策项目(HPB),以促进意大利妇产医院(MHs)的母乳喂养。HBP 项目是一项无对照的前后对比研究,目的是提高出生时体重正常的健康足月婴儿出院时的婴儿早产率:1) 成立当地医院工作组;2) 通过医院政策;3) 实施母乳喂养监测;4) 培训围产期护理专业人员;5) 加强皮肤接触 (SSC) 和母婴同室做法的实施;6) 制定/改进围产期护理协议:我们报告了在项目开始时(时间 1 或 T1)对 111 名注册产妇中的 89 名(80.2%)进行的干预前评估。几乎所有的医疗保健机构(96.6%)都成立了跨专业的母乳喂养工作组,而只有 48.2% 的医疗保健机构制定了母乳喂养的医院政策。此外,在 9 777 名围产期保健工作者中,只有 56.2% 接受过母乳喂养培训。在 1 个月的时间里,6 304 名足月产健康新生儿中有 76.9%在产房内进行了母乳喂养,6 735 名出生时体重正常的足月产健康新生儿中有 83.4%在产房内进行了母乳喂养。在 4 个月期间,33367 名出生时体重正常的足月健康新生儿中有 69.1%在出院时接受了纯母乳喂养。值得注意的是,产妇的纯母乳喂养率从 4% 到 100% 不等,第二四分位数为 73%:结论:在 HPB 项目的第一阶段,出生时体重正常的健康足月婴儿出院时的母乳喂养率在意大利产妇中似乎并不理想。特别是,参与中心的母乳喂养率范围很广,50% 的医疗机构的母乳喂养率低于 73%。因此,正在进行的HPB项目不仅是提高母乳喂养率和改善整个研究组医疗保健质量的机会,也可能是缩小中心间差异的机会。
{"title":"Promotion of breastfeeding in Italian Maternity Hospitals: a pre-intervention study.","authors":"Riccardo Davanzo, Guglielmo Salvatori, Mariella Baldassarre, Irene Cetin, Elsa Viora, Elena Scarpato","doi":"10.1186/s13052-024-01793-9","DOIUrl":"10.1186/s13052-024-01793-9","url":null,"abstract":"<p><strong>Background: </strong>In Italy, exclusive breastfeeding (EBF) rates at hospital discharge range unsatisfactorily between 20-97%.</p><p><strong>Methods: </strong>In 2023, the Project for Hospital Policy on Breastfeeding (HPB) has been launched to promote breastfeeding in Italian Maternity Hospitals (MHs) as a joint initiative of the Italian Scientific Societies involved in perinatal care together with the National Midwife (FNOPO) and Nurse (FNOPI) Boards and with Vivere Onlus, a family association. The HBP Project has been designed as an uncontrolled before-after study to increase EBF rate at hospital discharge in the population of healthy, term infant with a normal weight at birth following an intervention bundle comprising: 1) Establishment of a local hospital Working Group; 2) Adoption of a hospital policy; 3) Implementation of breastfeeding monitoring; 4) Training for perinatal care professionals; 5) Enhanced implementation of the practices of skin-to-skin contact (SSC) and mother-baby rooming-in; 6) Development/Improvement of perinatal care protocols.</p><p><strong>Results: </strong>We report the pre-intervention assessment of 89 out of the 111 enrolled MHs (80.2%) at the beginning of the Project (Time 1 or T1). Almost all MHs (96.6%) have a multi-professional Breastfeeding Working Group, while a hospital policy on breastfeeding is available only in 48.2%. Moreover, only 56.2% of the 9,777 perinatal health workers have been trained in breastfeeding. Over a 1-month period, SSC has been practiced in the delivery room by 76.9% of 6,304 term healthy newborn infants and rooming-in by 83.4% of 6,735 healthy term newborns of normal weight at birth. Over a 4-month period, 69.1% of 33,367 healthy term newborns of normal birth weight were exclusively breastfed at hospital discharge. Noticeably, EBF rate of MHs ranges from 4% up to 100%, the second quartile being 73%.</p><p><strong>Conclusion: </strong>At T1 of the HPB Project, breastfeeding rates at hospital discharge for healthy, term infants with a normal weight at birth appear to be suboptimal among Italians MHs. Particularly, the range of EBF rates among participating centers is wide, with 50% of the MHs having EBF rate lower than 73%. Therefore, the ongoing HPB Project might represent not only an opportunity to increase the initiation of breastfeeding and to improve quality of health care in the whole study group of MHs, but possibly also to level differences between centers.</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"50 1","pages":"219"},"PeriodicalIF":3.2,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11520110/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A smartphone app for preschool wheezing and reliability of medical history collection. 一款针对学龄前儿童喘息和病史收集可靠性的智能手机应用程序。
IF 3.2 3区 医学 Q1 PEDIATRICS Pub Date : 2024-10-25 DOI: 10.1186/s13052-024-01792-w
Nicola Ullmann, Adriana Fracchiolla, Alessandra Boni, Valentina Negro, Federica Porcaro, Antonio Di Marco, Salvatore Tripodi, Renato Cutrera

Background: The use of mobile applications helps improving self-management in adolescents with asthma. However, no evidence is available for children with preschool wheezing. In addition, we have no data on the reliability of medical history collected at visits. The first aim was to assess the feasibility of a smartphone app in the management of preschool wheezing; secondly we aimed to evaluate the reliability of anamnestic data collected during face-to-face medical interviews.

Methods: Children with recurrent wheezing, age between 25 and 72 months, were randomly assigned to the intervention group, provided with a smartphone app for symptoms monitoring and asthma attack treatment, or to the control group, with a written action plan. At follow-up medical history was collected and the asthma control test and a clinical questionnaire were completed. App acceptability was also explored. Respiratory symptoms, medication and utilization of healthcare resources were collected. Plus, medical information obtained from the paper questionnaires was compared with data daily recorded by the app.

Results: We enrolled 85 preschool children with recurrent wheezing: 43 assigned to the intervention and 42 to the control group. The average (SD) adherence to e-Diary compilation was 60 (15)%. The acceptance and usability of the intervention was favorable as 70% and 93% of participants in the intervention arm described the app as ''simple and intuitive'' at Visit1 (after 3 months from enrollement) and Visit2 (3 months later than Visit1), respectively and 95% and 98% found it useful in symptoms management. There were no significant differences between the two groups in clinical outcomes. At Visit1, the cACT median score (IQR) was 23,5 (21-25) for the control group (42 patients) and 23 (21-24) for the intervention group (43 patients). At Visit2 (41 controls and 42 in the intervention group) it was 25 (24-25) and 24 (24-25), respectively. Secondary analysis of data from the intervention group showed higher incidence of daily symptoms recorded by the app in comparison with the paper questionnaire, suggesting that collection of retrospective medical history may not be completely reliable.

Conclusions: The smartphone app is usable and acceptable by families of preschool wheezers. Future controlled trial are needed to prove an impact on clinical outcomes or its efficacy in a telemedicine program. Finally a daily questionnaire could provide physicians with a more reliable clinical picture as reflected better daily asthma symptoms than the written retrospective questionnaire filled at clinical visit.

背景:使用移动应用程序有助于改善青少年哮喘患者的自我管理。然而,对于学龄前喘息的儿童,目前还没有相关的证据。此外,我们也没有关于就诊时收集的病史可靠性的数据。我们的第一个目的是评估智能手机应用程序在学龄前喘息管理中的可行性;第二个目的是评估在面对面医疗访谈中收集的病史数据的可靠性:方法:将年龄在 25 到 72 个月之间、反复喘息的儿童随机分配到干预组和对照组,干预组使用智能手机应用程序进行症状监测和哮喘发作治疗,对照组则使用书面行动计划。随访时收集病史,完成哮喘控制测试和临床问卷调查。此外,还探讨了应用程序的可接受性。此外,还收集了呼吸道症状、用药情况和医疗资源使用情况。此外,还将从纸质问卷中获得的医疗信息与应用程序每天记录的数据进行了比较:我们招募了 85 名反复喘息的学龄前儿童:43 名分配到干预组,42 名分配到对照组。电子日记的平均(标清)坚持率为 60 (15)%。干预措施的接受度和可用性良好,干预组分别有 70% 和 93% 的参与者在第一次就诊(自注册起 3 个月后)和第二次就诊(比第一次就诊晚 3 个月)时认为该应用程序 "简单、直观",95% 和 98% 的参与者认为该应用程序有助于症状管理。两组患者的临床结果无明显差异。在第 1 次就诊时,对照组(42 名患者)的 cACT 中位数分数(IQR)为 23.5(21-25),干预组(43 名患者)的 cACT 中位数分数(IQR)为 23(21-24)。在第二次就诊时(对照组 41 人,干预组 42 人),中位数分别为 25 (24-25) 和 24 (24-25)。对干预组数据的二次分析表明,与纸质问卷相比,应用程序记录的日常症状发生率更高,这表明回顾病史的收集可能并不完全可靠:结论:学龄前喘息者家庭可以使用并接受智能手机应用程序。今后还需要进行对照试验,以证明其对临床结果的影响或在远程医疗项目中的有效性。最后,与临床就诊时填写的书面回顾性问卷相比,每日问卷可为医生提供更可靠的临床信息,更好地反映每日哮喘症状。
{"title":"A smartphone app for preschool wheezing and reliability of medical history collection.","authors":"Nicola Ullmann, Adriana Fracchiolla, Alessandra Boni, Valentina Negro, Federica Porcaro, Antonio Di Marco, Salvatore Tripodi, Renato Cutrera","doi":"10.1186/s13052-024-01792-w","DOIUrl":"10.1186/s13052-024-01792-w","url":null,"abstract":"<p><strong>Background: </strong>The use of mobile applications helps improving self-management in adolescents with asthma. However, no evidence is available for children with preschool wheezing. In addition, we have no data on the reliability of medical history collected at visits. The first aim was to assess the feasibility of a smartphone app in the management of preschool wheezing; secondly we aimed to evaluate the reliability of anamnestic data collected during face-to-face medical interviews.</p><p><strong>Methods: </strong>Children with recurrent wheezing, age between 25 and 72 months, were randomly assigned to the intervention group, provided with a smartphone app for symptoms monitoring and asthma attack treatment, or to the control group, with a written action plan. At follow-up medical history was collected and the asthma control test and a clinical questionnaire were completed. App acceptability was also explored. Respiratory symptoms, medication and utilization of healthcare resources were collected. Plus, medical information obtained from the paper questionnaires was compared with data daily recorded by the app.</p><p><strong>Results: </strong>We enrolled 85 preschool children with recurrent wheezing: 43 assigned to the intervention and 42 to the control group. The average (SD) adherence to e-Diary compilation was 60 (15)%. The acceptance and usability of the intervention was favorable as 70% and 93% of participants in the intervention arm described the app as ''simple and intuitive'' at Visit1 (after 3 months from enrollement) and Visit2 (3 months later than Visit1), respectively and 95% and 98% found it useful in symptoms management. There were no significant differences between the two groups in clinical outcomes. At Visit1, the cACT median score (IQR) was 23,5 (21-25) for the control group (42 patients) and 23 (21-24) for the intervention group (43 patients). At Visit2 (41 controls and 42 in the intervention group) it was 25 (24-25) and 24 (24-25), respectively. Secondary analysis of data from the intervention group showed higher incidence of daily symptoms recorded by the app in comparison with the paper questionnaire, suggesting that collection of retrospective medical history may not be completely reliable.</p><p><strong>Conclusions: </strong>The smartphone app is usable and acceptable by families of preschool wheezers. Future controlled trial are needed to prove an impact on clinical outcomes or its efficacy in a telemedicine program. Finally a daily questionnaire could provide physicians with a more reliable clinical picture as reflected better daily asthma symptoms than the written retrospective questionnaire filled at clinical visit.</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"50 1","pages":"220"},"PeriodicalIF":3.2,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11515270/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do preterm infants' retinas like bovine colostrum? A randomized controlled trial. 早产儿视网膜喜欢牛初乳吗?随机对照试验
IF 3.2 3区 医学 Q1 PEDIATRICS Pub Date : 2024-10-19 DOI: 10.1186/s13052-024-01781-z
Marwa Mohamed Farag, Mohamed Alaa Eldin Hassan Thabet, Islam Sh Ahmed, Nesrine Fathi Hanafi, Walaa Samy Elsawy, Eman Shabban Mohamed

Background: Bovine colostrum (BC) with liposomal delivery system (LDS) is a promising supplement to premature infant formula in absence of mother own milk. We propose that BC with LDS can target multiple etiological factors that threaten the developing retina, making premature infant less liable for retinopathy of prematurity (ROP). The aim of this study was to evaluate the effect of BC with LDS in the prevention of ROP.

Methods: This was a single center, randomized, controlled trial. Two hundred and eleven preterm infants of gestational age ≤ 32weeks were admitted to the NICU of Alexandria University Children Hospital, Egypt, and randomly allocated into either non-BC group (n = 105) or BC group (n = 106). Patients in BC group received 3.5 ml /kg/day of BC for 14 days. All patients were monitored for development of ROP, anemia, late onset sepsis (LOS), bronchopulmonary dysplasia (BPD), periventricular leukomalacia (PVL) and necrotizing enterocolitis (NEC), in addition to growth assessment. Multivariate binary logistic regression analysis was performed to determine factors predicting ROP development.

Results: Compared with the non-BC group, BC group was associated with a significantly lower incidence of ROP (5/100 vs. 16/100, respectively) with a p-value of 0.033. The administration of BC significantly decreased serum C- reactive protein (CRP) level and increased weight on day-14 of the study in comparison with the CRP level and birthweight at the beginning of study, with Cohen's D= -0.184, D = -2.246, respectively. Patients with suspected sepsis were significantly less in BC than non-BC group, p = 0.004. Patients with BC had significantly higher hemoglobin level on day-14 than non-BC-group, with median (IQR) 12.2 (11.0-13.9) and 11.7 (10.5-12.9), respectively. BC intake is one of factors that decreased development of ROP in univariate analysis. Nevertheless, weight gain and birth weight were the most significant factors affecting ROP development in multivariate-regression model.

Conclusion: BC may reduce the incidence of ROP in preterm neonates aged ≤ 32 weeks. This might be due to keeping better Hb level and growth rate, as well as anti-inflammatory properties through its ability to decrease CRP level.

Trial registration: This work was registered on 06/13/2022 in clinicaltrial.gov with ID no.: NCT05438680 and URL: https://classic.

Clinicaltrials: gov/ct2/show/NCT05438680?term=NCT05438680&draw=2&rank=1 .

背景:含脂质体输送系统(LDS)的牛初乳(BC)是一种很有前景的早产儿配方奶粉补充剂。我们认为,含脂质体输送系统的牛初乳可针对威胁视网膜发育的多种病因,降低早产儿患早产儿视网膜病变(ROP)的风险。本研究旨在评估含 LDS 的 BC 在预防早产儿视网膜病变方面的效果:这是一项单中心、随机对照试验。埃及亚历山大大学儿童医院新生儿重症监护室收治了 211 名胎龄小于 32 周的早产儿,他们被随机分配到非 BC 组(105 人)或 BC 组(106 人)。BC 组患者每天接受 3.5 毫升/千克的 BC,持续 14 天。除了进行生长评估外,还对所有患者的 ROP、贫血、晚发败血症 (LOS)、支气管肺发育不良 (BPD)、室周白斑 (PVL) 和坏死性小肠结肠炎 (NEC) 发展情况进行监测。研究人员进行了多变量二元逻辑回归分析,以确定预测ROP发生的因素:结果:与非 BC 组相比,BC 组的 ROP 发生率明显较低(分别为 5/100 和 16/100),P 值为 0.033。与研究开始时的血清 C 反应蛋白(CRP)水平和出生体重相比,服用 BC 可明显降低研究第 14 天的血清 C 反应蛋白(CRP)水平并增加体重,Cohen's D= -0.184,D = -2.246。BC 组疑似败血症患者明显少于非 BC 组,P = 0.004。BC 组患者第 14 天的血红蛋白水平明显高于非 BC 组,中位数(IQR)分别为 12.2(11.0-13.9)和 11.7(10.5-12.9)。在单变量分析中,BC摄入量是降低视网膜病变发生率的因素之一。然而,在多变量回归模型中,体重增加和出生体重是影响视网膜病变发生的最重要因素:BC可降低32周以下早产新生儿的视网膜病变发生率。结论:BC 可降低 32 周以下早产新生儿的 ROP 发生率,这可能是由于它能保持较好的血红蛋白水平和生长速度,并能降低 CRP 水平,从而具有抗炎特性:本研究于2022年6月13日在clinicaltrial.gov上注册,ID号为:NCT05438680,网址为:https://classic.Clinicaltrials: gov/ct2/show/NCT05438680?term=NCT05438680&draw=2&rank=1 。
{"title":"Do preterm infants' retinas like bovine colostrum? A randomized controlled trial.","authors":"Marwa Mohamed Farag, Mohamed Alaa Eldin Hassan Thabet, Islam Sh Ahmed, Nesrine Fathi Hanafi, Walaa Samy Elsawy, Eman Shabban Mohamed","doi":"10.1186/s13052-024-01781-z","DOIUrl":"10.1186/s13052-024-01781-z","url":null,"abstract":"<p><strong>Background: </strong>Bovine colostrum (BC) with liposomal delivery system (LDS) is a promising supplement to premature infant formula in absence of mother own milk. We propose that BC with LDS can target multiple etiological factors that threaten the developing retina, making premature infant less liable for retinopathy of prematurity (ROP). The aim of this study was to evaluate the effect of BC with LDS in the prevention of ROP.</p><p><strong>Methods: </strong>This was a single center, randomized, controlled trial. Two hundred and eleven preterm infants of gestational age ≤ 32weeks were admitted to the NICU of Alexandria University Children Hospital, Egypt, and randomly allocated into either non-BC group (n = 105) or BC group (n = 106). Patients in BC group received 3.5 ml /kg/day of BC for 14 days. All patients were monitored for development of ROP, anemia, late onset sepsis (LOS), bronchopulmonary dysplasia (BPD), periventricular leukomalacia (PVL) and necrotizing enterocolitis (NEC), in addition to growth assessment. Multivariate binary logistic regression analysis was performed to determine factors predicting ROP development.</p><p><strong>Results: </strong>Compared with the non-BC group, BC group was associated with a significantly lower incidence of ROP (5/100 vs. 16/100, respectively) with a p-value of 0.033. The administration of BC significantly decreased serum C- reactive protein (CRP) level and increased weight on day-14 of the study in comparison with the CRP level and birthweight at the beginning of study, with Cohen's D= -0.184, D = -2.246, respectively. Patients with suspected sepsis were significantly less in BC than non-BC group, p = 0.004. Patients with BC had significantly higher hemoglobin level on day-14 than non-BC-group, with median (IQR) 12.2 (11.0-13.9) and 11.7 (10.5-12.9), respectively. BC intake is one of factors that decreased development of ROP in univariate analysis. Nevertheless, weight gain and birth weight were the most significant factors affecting ROP development in multivariate-regression model.</p><p><strong>Conclusion: </strong>BC may reduce the incidence of ROP in preterm neonates aged ≤ 32 weeks. This might be due to keeping better Hb level and growth rate, as well as anti-inflammatory properties through its ability to decrease CRP level.</p><p><strong>Trial registration: </strong>This work was registered on 06/13/2022 in clinicaltrial.gov with ID no.: NCT05438680 and URL: https://classic.</p><p><strong>Clinicaltrials: </strong>gov/ct2/show/NCT05438680?term=NCT05438680&draw=2&rank=1 .</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"50 1","pages":"218"},"PeriodicalIF":3.2,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11490996/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of mild to moderate community-acquired pneumonia in previously healthy children: an Italian intersociety consensus (SIPPS-SIP-SITIP-FIMP-SIAIP-SIMRI-FIMMG-SIMG). 既往健康儿童轻中度社区获得性肺炎的治疗:意大利学会间共识(SIPPS-SIP-SITIP-FIMP-SIAIP-SIMRI-FIMMG-SIMG)。
IF 3.2 3区 医学 Q1 PEDIATRICS Pub Date : 2024-10-19 DOI: 10.1186/s13052-024-01786-8
Daniele Donà, Giulia Brigadoi, Roberto Grandinetti, Laura Pedretti, Giovanni Boscarino, Elisa Barbieri, Luigi Matera, Enrica Mancino, Marcello Bergamini, Guido Castelli Gattinara, Elena Chiappini, Mattia Doria, Luisa Galli, Alfredo Guarino, Andrea Lo Vecchio, Elisabetta Venturini, Gianluigi Marseglia, Maria Carmen Verga, Giuseppe Di Mauro, Nicola Principi, Fabio Midulla, Susanna Esposito

Community-acquired pneumonia (CAP) is an acute infection of the lung parenchyma acquired outside the hospital or other healthcare settings, typically affecting previously healthy individuals. This intersociety consensus aims to provide evidence-based recommendations for the antibiotic treatment of mild to moderate CAP in previously healthy children in Italy.A systematic review was conducted to identify the most recent and relevant evidence. Embase, Scopus, PubMed, and Cochrane databases were systematically screened, with a date restriction from 2012 to April 2024, but without language limitations. The review included studies conducted in high-income countries on antibiotic therapy in children over 3 months of age diagnosed with mild-moderate CAP. The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methods. The final recommendations were obtained through a Delphi consensus of an expert panel.Amoxicillin is the first-line treatment if the child is at least immunized against Haemophilus influenzae type b (low/very low quality of evidence, strong recommendations), while amoxicillin-clavulanate or second- or third-generation cephalosporins should be prescribed for those unimmunized or with incomplete immunization coverage for both H. influenzae type b and Streptococcus pneumoniae (low/very low quality of evidence, strong recommendations). Macrolides should be considered in addition to amoxicillin in children over 5 years old, if symptoms persist and the clinical condition remains good after 48 h of therapy (low/very low quality of evidence, strong recommendations). The dosage of amoxicillin is 90 mg/kg/day divided in three doses, although two doses could be considered to improve compliance (moderate quality of evidence, weak recommendations). A five-day duration of therapy is recommended, with clinical monitoring and re-assessment approximately 72 h after the start of antibiotic treatment to evaluate symptom resolution (moderate quality of evidence, strong recommendations).To improve the management of CAP in pediatric patients, we have developed this consensus based on a thorough review of the best available evidence and extensive discussions with an expert panel. However, further efforts are needed. Future research should focus on enhancing diagnostic accuracy, optimizing antibiotic utilization, comparing the efficacy of different antibiotic regimens, and determining the optimal dosage and duration of treatment in different setting.

社区获得性肺炎(CAP)是一种在医院或其他医疗机构外获得的肺实质急性感染,通常影响以前健康的人。本协会间共识旨在为意大利既往健康儿童轻度至中度 CAP 的抗生素治疗提供循证建议。对 Embase、Scopus、PubMed 和 Cochrane 数据库进行了系统性筛选,日期限制为 2012 年至 2024 年 4 月,但无语言限制。综述纳入了在高收入国家进行的关于对 3 个月以上诊断为轻度-中度 CAP 的儿童进行抗生素治疗的研究。采用建议评估、发展和评价分级(GRADE)方法对证据的确定性进行了评估。如果儿童至少接种了 b 型流感嗜血杆菌疫苗,阿莫西林是一线治疗药物(证据质量低/极低,强烈建议),而对于未接种或未完全接种 b 型流感嗜血杆菌和链球菌疫苗的儿童,应处方阿莫西林-克拉维酸或第二代或第三代头孢菌素。b 型流感嗜血杆菌和肺炎链球菌(证据质量低/极低,强烈建议)。对于 5 岁以上的儿童,如果症状持续存在,且治疗 48 小时后临床状况仍然良好,则除阿莫西林外还应考虑使用大环内酯类药物(证据质量低/极低,强烈建议)。阿莫西林的剂量为 90 毫克/千克/天,分三次服用,但也可考虑分两次服用,以提高依从性(中等证据质量,弱建议)。建议疗程为五天,并在抗生素治疗开始后 72 小时左右进行临床监测和重新评估,以评估症状的缓解情况(中等证据质量,强建议)。为改善儿科患者的 CAP 管理,我们在全面回顾现有最佳证据并与专家小组进行广泛讨论的基础上达成了这一共识。然而,我们还需要进一步努力。未来的研究重点应放在提高诊断准确性、优化抗生素的使用、比较不同抗生素方案的疗效以及确定不同情况下的最佳剂量和疗程上。
{"title":"Treatment of mild to moderate community-acquired pneumonia in previously healthy children: an Italian intersociety consensus (SIPPS-SIP-SITIP-FIMP-SIAIP-SIMRI-FIMMG-SIMG).","authors":"Daniele Donà, Giulia Brigadoi, Roberto Grandinetti, Laura Pedretti, Giovanni Boscarino, Elisa Barbieri, Luigi Matera, Enrica Mancino, Marcello Bergamini, Guido Castelli Gattinara, Elena Chiappini, Mattia Doria, Luisa Galli, Alfredo Guarino, Andrea Lo Vecchio, Elisabetta Venturini, Gianluigi Marseglia, Maria Carmen Verga, Giuseppe Di Mauro, Nicola Principi, Fabio Midulla, Susanna Esposito","doi":"10.1186/s13052-024-01786-8","DOIUrl":"10.1186/s13052-024-01786-8","url":null,"abstract":"<p><p>Community-acquired pneumonia (CAP) is an acute infection of the lung parenchyma acquired outside the hospital or other healthcare settings, typically affecting previously healthy individuals. This intersociety consensus aims to provide evidence-based recommendations for the antibiotic treatment of mild to moderate CAP in previously healthy children in Italy.A systematic review was conducted to identify the most recent and relevant evidence. Embase, Scopus, PubMed, and Cochrane databases were systematically screened, with a date restriction from 2012 to April 2024, but without language limitations. The review included studies conducted in high-income countries on antibiotic therapy in children over 3 months of age diagnosed with mild-moderate CAP. The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methods. The final recommendations were obtained through a Delphi consensus of an expert panel.Amoxicillin is the first-line treatment if the child is at least immunized against Haemophilus influenzae type b (low/very low quality of evidence, strong recommendations), while amoxicillin-clavulanate or second- or third-generation cephalosporins should be prescribed for those unimmunized or with incomplete immunization coverage for both H. influenzae type b and Streptococcus pneumoniae (low/very low quality of evidence, strong recommendations). Macrolides should be considered in addition to amoxicillin in children over 5 years old, if symptoms persist and the clinical condition remains good after 48 h of therapy (low/very low quality of evidence, strong recommendations). The dosage of amoxicillin is 90 mg/kg/day divided in three doses, although two doses could be considered to improve compliance (moderate quality of evidence, weak recommendations). A five-day duration of therapy is recommended, with clinical monitoring and re-assessment approximately 72 h after the start of antibiotic treatment to evaluate symptom resolution (moderate quality of evidence, strong recommendations).To improve the management of CAP in pediatric patients, we have developed this consensus based on a thorough review of the best available evidence and extensive discussions with an expert panel. However, further efforts are needed. Future research should focus on enhancing diagnostic accuracy, optimizing antibiotic utilization, comparing the efficacy of different antibiotic regimens, and determining the optimal dosage and duration of treatment in different setting.</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"50 1","pages":"217"},"PeriodicalIF":3.2,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11491012/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare cause of respiratory distress in preterm infants: a case report of acquired subglottic cysts. 早产儿呼吸窘迫的罕见病因:获得性声门下囊肿病例报告。
IF 3.2 3区 医学 Q1 PEDIATRICS Pub Date : 2024-10-16 DOI: 10.1186/s13052-024-01784-w
Luca Barchi, Giulia Russo, Sara Donvito, Giulia Barbato, Francesco Leo, Elisa Iannella, Angelo Ghidini, Lorenzo Iughetti, Giancarlo Gargano

Background: The Subglottic Cysts (SGCs) are a rare cause of respiratory distress in infants. Typical risk factors include male gender, extreme prematurity, gastro-oesophageal reflux and invasive ventilation, the latter being associated with mucosal damage and blockage of the subglottic cysts' ducts. We describe a case of acquired subglottic cysts in a premature infants presented with respiratory distress.

Case presentation: A premature male infant was born at 25 weeks + 2 days with a history of monochorionic diamniotic twin pregnancy with twin-to-twin transfusion syndrome. During hospitalization, invasive mechanical ventilation was necessary for a total of 18 days; the patient was discharged at postmenstrual age of 40 weeks + 1 day in good condition. At 43 weeks post-menstrual age, he presented to our department with mixed stridor and worsening of respiratory dynamics. A laryngotracheoscopy evaluation was performed. The exam showed the presence of multiple SGCs causing an almost complete obstruction of the airway. Because of the significant reduction of the airway's patency, the child underwent a tracheotomy and thereafter cysts' removal using cold steel microinstruments. A better airway patency was restored although a slight glottic edema persisted. The histopathology confirmed the benign nature of the lesions. Successive controls showed a completely patent airway and absence of SGCs.

Conclusion: In conclusion, SGCs should be considered in preterm infants with respiratory distress previously intubated, which cannot be explained by the most common causes. Early diagnosis and treatment are fundamental to reducing the morbidity and mortality associated with this disease.

背景:声门下囊肿(SGC)是导致婴儿呼吸窘迫的罕见原因。典型的危险因素包括男性、极度早产、胃食管反流和有创通气,后者与粘膜损伤和声门下囊肿导管堵塞有关。我们描述了一例出现呼吸窘迫的早产儿获得性声门下囊肿病例:一名早产男婴于 25 周+2 天时出生,患有单绒毛膜双羊膜妊娠和双胎输血综合征。住院期间,患者需要进行有创机械通气共 18 天;患者于月经后 40 周+1 天出院,情况良好。月经后 43 周时,他因混合性哮鸣音和呼吸动力学恶化来到我科就诊。我们对他进行了喉气管镜检查。检查结果显示,多发性 SGCs 几乎完全阻塞了气道。由于气道的通畅性明显下降,患儿接受了气管切开术,随后使用冷钢微型器械切除了囊肿。虽然声门仍有轻微水肿,但气道的通畅性已经恢复。组织病理学证实病变为良性。连续的对照显示气道完全通畅,没有 SGCs:总之,早产儿出现呼吸困难并插管后,如果无法用最常见的原因来解释,则应考虑 SGCs。早期诊断和治疗是降低该病发病率和死亡率的基础。
{"title":"A rare cause of respiratory distress in preterm infants: a case report of acquired subglottic cysts.","authors":"Luca Barchi, Giulia Russo, Sara Donvito, Giulia Barbato, Francesco Leo, Elisa Iannella, Angelo Ghidini, Lorenzo Iughetti, Giancarlo Gargano","doi":"10.1186/s13052-024-01784-w","DOIUrl":"https://doi.org/10.1186/s13052-024-01784-w","url":null,"abstract":"<p><strong>Background: </strong>The Subglottic Cysts (SGCs) are a rare cause of respiratory distress in infants. Typical risk factors include male gender, extreme prematurity, gastro-oesophageal reflux and invasive ventilation, the latter being associated with mucosal damage and blockage of the subglottic cysts' ducts. We describe a case of acquired subglottic cysts in a premature infants presented with respiratory distress.</p><p><strong>Case presentation: </strong>A premature male infant was born at 25 weeks + 2 days with a history of monochorionic diamniotic twin pregnancy with twin-to-twin transfusion syndrome. During hospitalization, invasive mechanical ventilation was necessary for a total of 18 days; the patient was discharged at postmenstrual age of 40 weeks + 1 day in good condition. At 43 weeks post-menstrual age, he presented to our department with mixed stridor and worsening of respiratory dynamics. A laryngotracheoscopy evaluation was performed. The exam showed the presence of multiple SGCs causing an almost complete obstruction of the airway. Because of the significant reduction of the airway's patency, the child underwent a tracheotomy and thereafter cysts' removal using cold steel microinstruments. A better airway patency was restored although a slight glottic edema persisted. The histopathology confirmed the benign nature of the lesions. Successive controls showed a completely patent airway and absence of SGCs.</p><p><strong>Conclusion: </strong>In conclusion, SGCs should be considered in preterm infants with respiratory distress previously intubated, which cannot be explained by the most common causes. Early diagnosis and treatment are fundamental to reducing the morbidity and mortality associated with this disease.</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"50 1","pages":"216"},"PeriodicalIF":3.2,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11484475/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Promising predictors of diabetic peripheral neuropathy in children and adolescents with type 1 diabetes mellitus. 1 型糖尿病儿童和青少年糖尿病周围神经病变的前景预测。
IF 3.2 3区 医学 Q1 PEDIATRICS Pub Date : 2024-10-14 DOI: 10.1186/s13052-024-01774-y
Ahmed S Abo Hola, Sameh A Abd El Naby, Esraa T Allam, Ayaat A Gab Allah, Dina A Hammad

Background: Diabetic peripheral neuropathy (DPN) in children and adolescents with type 1 diabetes mellitus (T1DM) is a growing issue, with controversial data in the terms of prevalence and evaluation timelines. Currently, there are no clear standards for its early detection. Therefore, our aim was to assess the contribution of the Michigan neuropathy screening instrument (MNSI), lipid profile, serum neuron specific enolase (NSE), and serum heat shock protein 27 (HSP 27) to the prediction of DPN in children and adolescents with T1DM.

Methods: In this case-control study, fifty children diagnosed with T1DM for at least five years were enrolled and evaluated through complete neurological examination, MNSI, and nerve conduction study (NCS). Additionally, HbA1c, lipid profile, serum NSE, and serum HSP 27 levels were measured for patients and controls.

Results: The prevalence of DPN in our study was 24% by NCS, and electrophysiological changes showed a statistically significant lower conduction velocity for the posterior tibial and sural nerves, as well as a prolonged latency period for the common peroneal and sural nerves in neuropathic patients. In these patients, older age, earlier age of diabetes onset, longer disease duration, higher total cholesterol, triglycerides, low density lipoprotein cholesterol, HbA1c, serum NSE, and HSP27 levels were observed. The MNSI examination score ≥ 1.5 cutoff point had an area under the curve (AUC) of 0.955, with 75% sensitivity and 94.74% specificity, according to receiver operating characteristic curve analysis. However, the questionnaire's cutoff point of ≥ 5 had an AUC of 0.720, 75% sensitivity, and 63% specificity, with improved overall instrument performance when combining both scores. Regarding blood biomarkers, serum NSE had greater sensitivity and specificity in discriminating neuropathic patients than HSP27 (92% and 74% versus 75% and 71%, respectively). Regression analysis revealed a substantial dependency for MNSI and serum NSE in predicting DPN in patients.

Conclusions: Despite limited research in pediatrics, MNSI and serum NSE are promising predictive tools for DPN in children and adolescents with T1DM, even when they are asymptomatic. Poor glycemic control and lipid profile changes may play a critical role in the development of DPN in these patients, despite conflicting results in various studies.

背景:1 型糖尿病(T1DM)儿童和青少年的糖尿病周围神经病变(DPN)是一个日益严重的问题,在发病率和评估时限方面的数据存在争议。目前,还没有明确的早期检测标准。因此,我们的目的是评估密歇根神经病变筛查工具(MNSI)、血脂谱、血清神经元特异性烯醇化酶(NSE)和血清热休克蛋白 27(HSP 27)对预测 T1DM 儿童和青少年 DPN 的贡献:在这项病例对照研究中,50 名儿童被诊断患有 T1DM 至少 5 年,他们接受了全面的神经系统检查、MNSI 和神经传导研究(NCS)。此外,还测量了患者和对照组的 HbA1c、血脂、血清 NSE 和血清 HSP 27 水平:电生理学变化显示,神经病变患者的胫后神经和苏木神经的传导速度明显降低,腓总神经和苏木神经的潜伏期延长。这些患者的年龄较大,糖尿病发病年龄较早,病程较长,总胆固醇、甘油三酯、低密度脂蛋白胆固醇、HbA1c、血清 NSE 和 HSP27 水平较高。根据接收者操作特征曲线分析,MNSI检查得分≥1.5的临界点的曲线下面积(AUC)为0.955,敏感性为75%,特异性为94.74%。然而,问卷≥5分的临界点的AUC为0.720,灵敏度为75%,特异性为63%,将两个分数合并后,仪器的整体性能有所改善。在血液生物标记物方面,血清 NSE 在鉴别神经病变患者方面的灵敏度和特异性均高于 HSP27(灵敏度和特异性分别为 92% 和 74% 对 75% 和 71%)。回归分析表明,MNSI和血清NSE在预测DPN患者方面有很大的依赖性:结论:尽管儿科研究有限,但 MNSI 和血清 NSE 是预测 T1DM 儿童和青少年 DPN 的有前途的工具,即使他们没有症状。血糖控制不佳和血脂变化可能在这些患者的 DPN 发展过程中起到关键作用,尽管不同研究的结果存在冲突。
{"title":"Promising predictors of diabetic peripheral neuropathy in children and adolescents with type 1 diabetes mellitus.","authors":"Ahmed S Abo Hola, Sameh A Abd El Naby, Esraa T Allam, Ayaat A Gab Allah, Dina A Hammad","doi":"10.1186/s13052-024-01774-y","DOIUrl":"https://doi.org/10.1186/s13052-024-01774-y","url":null,"abstract":"<p><strong>Background: </strong>Diabetic peripheral neuropathy (DPN) in children and adolescents with type 1 diabetes mellitus (T1DM) is a growing issue, with controversial data in the terms of prevalence and evaluation timelines. Currently, there are no clear standards for its early detection. Therefore, our aim was to assess the contribution of the Michigan neuropathy screening instrument (MNSI), lipid profile, serum neuron specific enolase (NSE), and serum heat shock protein 27 (HSP 27) to the prediction of DPN in children and adolescents with T1DM.</p><p><strong>Methods: </strong>In this case-control study, fifty children diagnosed with T1DM for at least five years were enrolled and evaluated through complete neurological examination, MNSI, and nerve conduction study (NCS). Additionally, HbA1c, lipid profile, serum NSE, and serum HSP 27 levels were measured for patients and controls.</p><p><strong>Results: </strong>The prevalence of DPN in our study was 24% by NCS, and electrophysiological changes showed a statistically significant lower conduction velocity for the posterior tibial and sural nerves, as well as a prolonged latency period for the common peroneal and sural nerves in neuropathic patients. In these patients, older age, earlier age of diabetes onset, longer disease duration, higher total cholesterol, triglycerides, low density lipoprotein cholesterol, HbA1c, serum NSE, and HSP27 levels were observed. The MNSI examination score ≥ 1.5 cutoff point had an area under the curve (AUC) of 0.955, with 75% sensitivity and 94.74% specificity, according to receiver operating characteristic curve analysis. However, the questionnaire's cutoff point of ≥ 5 had an AUC of 0.720, 75% sensitivity, and 63% specificity, with improved overall instrument performance when combining both scores. Regarding blood biomarkers, serum NSE had greater sensitivity and specificity in discriminating neuropathic patients than HSP27 (92% and 74% versus 75% and 71%, respectively). Regression analysis revealed a substantial dependency for MNSI and serum NSE in predicting DPN in patients.</p><p><strong>Conclusions: </strong>Despite limited research in pediatrics, MNSI and serum NSE are promising predictive tools for DPN in children and adolescents with T1DM, even when they are asymptomatic. Poor glycemic control and lipid profile changes may play a critical role in the development of DPN in these patients, despite conflicting results in various studies.</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"50 1","pages":"215"},"PeriodicalIF":3.2,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11479551/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dysfunction of γδ T cells in pediatric chronic active Epstein-Barr virus infection. 小儿慢性活动性 Epstein-Barr 病毒感染中 γδ T 细胞的功能障碍。
IF 3.2 3区 医学 Q1 PEDIATRICS Pub Date : 2024-10-12 DOI: 10.1186/s13052-024-01783-x
Junhong Ai, Haijuan Xiao, Linlin Zhang, Honghao Ma, Dong Wang, Dilara Dilmurat, Ran Wang, Zhengde Xie

Chronic active Epstein-Barr virus infection (CAEBV) is a progressive and life-threatening disease characterized by persistent or recurrent EBV activation. It has been reported that, γδ T cells, a type of cytotoxic lymphocyte, play a critical role in restricting EBV. However, the functional status of γδ T cells in pediatric CAEBV patients has not yet been described. In this study, flow cytometry analysis was conducted to explore the cytokine production capacity of γδ T cells in CAEBV patients. A diminished frequency of γδ T cells and decreased expression of cytolytic molecule granzyme B were found in CAEBV patients, suggesting a dysfunction in the immune regulatory function of γδ T cells in this disease.

慢性活动性爱泼斯坦-巴氏病毒感染(CAEBV)是一种进行性和危及生命的疾病,其特点是持续或反复的 EBV 激活。据报道,γδ T 细胞是一种细胞毒性淋巴细胞,在限制 EBV 方面发挥着关键作用。然而,γδ T 细胞在小儿 CAEBV 患者中的功能状态尚未得到描述。本研究通过流式细胞术分析,探讨了 CAEBV 患者中 γδ T 细胞产生细胞因子的能力。研究发现,CAEBV 患者体内γδ T 细胞的频率降低,细胞溶解分子颗粒酶 B 的表达减少,这表明该疾病中γδ T 细胞的免疫调节功能失调。
{"title":"Dysfunction of γδ T cells in pediatric chronic active Epstein-Barr virus infection.","authors":"Junhong Ai, Haijuan Xiao, Linlin Zhang, Honghao Ma, Dong Wang, Dilara Dilmurat, Ran Wang, Zhengde Xie","doi":"10.1186/s13052-024-01783-x","DOIUrl":"https://doi.org/10.1186/s13052-024-01783-x","url":null,"abstract":"<p><p>Chronic active Epstein-Barr virus infection (CAEBV) is a progressive and life-threatening disease characterized by persistent or recurrent EBV activation. It has been reported that, γδ T cells, a type of cytotoxic lymphocyte, play a critical role in restricting EBV. However, the functional status of γδ T cells in pediatric CAEBV patients has not yet been described. In this study, flow cytometry analysis was conducted to explore the cytokine production capacity of γδ T cells in CAEBV patients. A diminished frequency of γδ T cells and decreased expression of cytolytic molecule granzyme B were found in CAEBV patients, suggesting a dysfunction in the immune regulatory function of γδ T cells in this disease.</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"50 1","pages":"213"},"PeriodicalIF":3.2,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11470581/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ambulatory blood pressure monitoring in Egyptian children with nephrotic syndrome: single center experience. 埃及肾病综合征患儿的动态血压监测:单中心经验。
IF 3.2 3区 医学 Q1 PEDIATRICS Pub Date : 2024-10-12 DOI: 10.1186/s13052-024-01775-x
Eman Abobakr Abd Alazem, Sonia Ali El-Saiedi, Shradha Chitrakar, Shorouk A Othman

Background: Hypertension (HTN), especially masked hypertension, is one of the cardiovascular consequences of nephrotic syndrome. Masked hypertension cannot be identified during routine follow-up visits and adversely effects the patients' cardiac function. The purpose of this study was to use ambulatory blood pressure monitoring (ABPM) to evaluate the blood pressure status of children with nephrotic syndrome.

Methods: Ninety children with nephrotic syndrome (NS) participated in this cross-sectional study, which was carried out at Cairo University Children Hospital's nephrology clinic (CUCH). A sphygmomanometer was used in the clinic to measure blood pressure, and a Meditech monitor was used for 24-hour ambulatory blood pressure monitoring (ABPM). Interventricular septum (IVS) was measured, and heart functions were evaluated, using echocardiography.

Results: Two groups comprised the included patients: Group1 (n = 70): HTN group included masked and ambulatory hypertension, and Group 2 (n = 20): non-HTN group included normal blood pressure, white coat HTN and well controlled HTN, 35% of the studied cohort (n = 32/90) had masked HTN.The serum urea was significantly higher in HTN group than non-HTN group with p-value: 0.047, while the serum albumin was significantly lower in HTN group than non-HTN group with p-value: 0.017. The cut-off point of 9.9, the sensitivity and specificity of serum urea to predict the occurrence of hypertension in NS patients was 92.9% and 35% respectively, with p-value : 0.024 and 95% CI (0.534-0.798). The z score of IVS is significantly higher in group 1 (2.5 ± 1.2) when compared to group 2 (1.7 ± 2.1) with p-value: 0.025 and Among group 1, it was noticed that 74% (n = 52/70) of them were systolic non-dipper, also it was observed that the mean serum potassium and cholesterol were significantly higher among systolic non-dipper when compared with systolic dipper patients with p-values: 0.045 and 0.005 respectively.

Conclusion: Children with nephrotic syndrome are particularly vulnerable to experience ambulatory hypertension and masked hypertension, which may adversely impact their cardiac condition because they are not detectable by standard blood pressure readings at the clinic.

背景:高血压(HTN),尤其是隐匿性高血压,是肾病综合征对心血管造成的后果之一。掩盖性高血压无法在常规随访中发现,并对患者的心脏功能造成不利影响。本研究旨在使用动态血压监测(ABPM)评估肾病综合征患儿的血压状况:这项横断面研究在开罗大学儿童医院肾病诊所(CUCH)进行,共有 90 名肾病综合征(NS)患儿参加。诊所使用血压计测量血压,并使用 Meditech 监护仪进行 24 小时动态血压监测 (ABPM)。使用超声心动图测量室间隔(IVS)并评估心脏功能:患者分为两组:第一组(n = 70):血清尿素在高血压组明显高于非高血压组,P 值为 0.047,而血清白蛋白在高血压组明显低于非高血压组,P 值为 0.017。以 9.9 为临界点,血清尿素预测 NS 患者发生高血压的敏感性和特异性分别为 92.9% 和 35%,p 值为 0.024,95% CI 为 0.534-0.798。第 1 组(2.5 ± 1.2)的 IVS z 评分明显高于第 2 组(1.7 ± 2.1),p 值为 0.025;在第 1 组中,74%(n = 52/70)的患者为收缩期非低血压患者,同时观察到收缩期非低血压患者的平均血清钾和胆固醇明显高于收缩期低血压患者,p 值分别为 0.045 和 0.0000:结论:肾病综合征患儿特别容易患上流动性高血压和隐匿性高血压,这可能会对他们的心脏状况产生不利影响,因为在诊所里无法通过标准血压读数检测到这些症状。
{"title":"Ambulatory blood pressure monitoring in Egyptian children with nephrotic syndrome: single center experience.","authors":"Eman Abobakr Abd Alazem, Sonia Ali El-Saiedi, Shradha Chitrakar, Shorouk A Othman","doi":"10.1186/s13052-024-01775-x","DOIUrl":"https://doi.org/10.1186/s13052-024-01775-x","url":null,"abstract":"<p><strong>Background: </strong>Hypertension (HTN), especially masked hypertension, is one of the cardiovascular consequences of nephrotic syndrome. Masked hypertension cannot be identified during routine follow-up visits and adversely effects the patients' cardiac function. The purpose of this study was to use ambulatory blood pressure monitoring (ABPM) to evaluate the blood pressure status of children with nephrotic syndrome.</p><p><strong>Methods: </strong>Ninety children with nephrotic syndrome (NS) participated in this cross-sectional study, which was carried out at Cairo University Children Hospital's nephrology clinic (CUCH). A sphygmomanometer was used in the clinic to measure blood pressure, and a Meditech monitor was used for 24-hour ambulatory blood pressure monitoring (ABPM). Interventricular septum (IVS) was measured, and heart functions were evaluated, using echocardiography.</p><p><strong>Results: </strong>Two groups comprised the included patients: Group1 (n = 70): HTN group included masked and ambulatory hypertension, and Group 2 (n = 20): non-HTN group included normal blood pressure, white coat HTN and well controlled HTN, 35% of the studied cohort (n = 32/90) had masked HTN.The serum urea was significantly higher in HTN group than non-HTN group with p-value: 0.047, while the serum albumin was significantly lower in HTN group than non-HTN group with p-value: 0.017. The cut-off point of 9.9, the sensitivity and specificity of serum urea to predict the occurrence of hypertension in NS patients was 92.9% and 35% respectively, with p-value : 0.024 and 95% CI (0.534-0.798). The z score of IVS is significantly higher in group 1 (2.5 ± 1.2) when compared to group 2 (1.7 ± 2.1) with p-value: 0.025 and Among group 1, it was noticed that 74% (n = 52/70) of them were systolic non-dipper, also it was observed that the mean serum potassium and cholesterol were significantly higher among systolic non-dipper when compared with systolic dipper patients with p-values: 0.045 and 0.005 respectively.</p><p><strong>Conclusion: </strong>Children with nephrotic syndrome are particularly vulnerable to experience ambulatory hypertension and masked hypertension, which may adversely impact their cardiac condition because they are not detectable by standard blood pressure readings at the clinic.</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"50 1","pages":"214"},"PeriodicalIF":3.2,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11470724/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of Methicillin-resistant Staphylococcus aureus infection in children with acute osteomyelitis. 急性骨髓炎患儿耐甲氧西林金黄色葡萄球菌感染的预测因素。
IF 3.2 3区 医学 Q1 PEDIATRICS Pub Date : 2024-10-10 DOI: 10.1186/s13052-024-01780-0
Kang Wang, Chen Wang, Hua Zhu, Yan Zou, Yanhua Feng, Fang Zhang, Yi Qu, Yiren Tian

Background: This study aims to identify risk factors associated with Methicillin-resistant Staphylococcus aureus (MRSA) infection in children diagnosed with acute osteomyelitis (AO) and to elucidate the laboratory characteristics of these MRSA-infected children to enhance early targeted therapeutic interventions.

Methods: We conducted a retrospective analysis involving 123 children with acute osteomyelitis treated at our hospital. Upon admission, we measured white blood cell (WBC) counts, C-reactive protein (CRP) levels, erythrocyte sedimentation rates (ESR), and platelet counts. Patients were categorized into two groups: the non-MRSA group (n = 73) and the MRSA group (n = 50), with values assigned as follows (non-MRSA group = 0, MRSA group = 1).

Results: The MRSA group had a significantly higher average age compared to the non-MRSA group (P < 0.05). Notably, the incidence of suppurative arthritis was significantly lower in the MRSA group (P < 0.05). At the time of admission, CRP levels in the MRSA group were markedly elevated compared to those in the non-MRSA group (P < 0.01). After three days of empirical therapy, both WBC and CRP levels remained significantly higher in the MRSA group compared to the non-MRSA group (P < 0.05).

Conclusions: In children newly admitted with acute osteomyelitis, a CRP level exceeding 73.23 µg/mL may indicate a high likelihood of MRSA infection. For children with AO who have been hospitalized for three days on empirical therapy, the presence of WBC > 10.95 × 10^9/L, CRP > 49.56 µg/mL, age > 3.5 years, and the absence of suppurative arthritis suggests a heightened risk of MRSA infection.

背景:本研究旨在确定急性骨髓炎(AO)患儿感染耐甲氧西林金黄色葡萄球菌(MRSA)的相关风险因素,并阐明这些MRSA感染患儿的实验室特征,以加强早期针对性治疗干预:我们对本院收治的123名急性骨髓炎患儿进行了回顾性分析。入院时,我们测量了白细胞(WBC)计数、C反应蛋白(CRP)水平、红细胞沉降率(ESR)和血小板计数。患者被分为两组:非 MRSA 组(n = 73)和 MRSA 组(n = 50),数值分配如下(非 MRSA 组 = 0,MRSA 组 = 1):结果:MRSA组的平均年龄明显高于非MRSA组(P 结论:MRSA组的平均年龄明显高于非MRSA组:对于新入院的急性骨髓炎患儿,CRP水平超过73.23 µg/mL可能预示着极有可能感染MRSA。对于住院三天并接受经验性治疗的急性骨髓炎患儿,如果白细胞大于 10.95 × 10^9/L、CRP 大于 49.56 µg/mL、年龄大于 3.5 岁、无化脓性关节炎,则表明感染 MRSA 的风险较高。
{"title":"Predictors of Methicillin-resistant Staphylococcus aureus infection in children with acute osteomyelitis.","authors":"Kang Wang, Chen Wang, Hua Zhu, Yan Zou, Yanhua Feng, Fang Zhang, Yi Qu, Yiren Tian","doi":"10.1186/s13052-024-01780-0","DOIUrl":"10.1186/s13052-024-01780-0","url":null,"abstract":"<p><strong>Background: </strong>This study aims to identify risk factors associated with Methicillin-resistant Staphylococcus aureus (MRSA) infection in children diagnosed with acute osteomyelitis (AO) and to elucidate the laboratory characteristics of these MRSA-infected children to enhance early targeted therapeutic interventions.</p><p><strong>Methods: </strong>We conducted a retrospective analysis involving 123 children with acute osteomyelitis treated at our hospital. Upon admission, we measured white blood cell (WBC) counts, C-reactive protein (CRP) levels, erythrocyte sedimentation rates (ESR), and platelet counts. Patients were categorized into two groups: the non-MRSA group (n = 73) and the MRSA group (n = 50), with values assigned as follows (non-MRSA group = 0, MRSA group = 1).</p><p><strong>Results: </strong>The MRSA group had a significantly higher average age compared to the non-MRSA group (P < 0.05). Notably, the incidence of suppurative arthritis was significantly lower in the MRSA group (P < 0.05). At the time of admission, CRP levels in the MRSA group were markedly elevated compared to those in the non-MRSA group (P < 0.01). After three days of empirical therapy, both WBC and CRP levels remained significantly higher in the MRSA group compared to the non-MRSA group (P < 0.05).</p><p><strong>Conclusions: </strong>In children newly admitted with acute osteomyelitis, a CRP level exceeding 73.23 µg/mL may indicate a high likelihood of MRSA infection. For children with AO who have been hospitalized for three days on empirical therapy, the presence of WBC > 10.95 × 10^9/L, CRP > 49.56 µg/mL, age > 3.5 years, and the absence of suppurative arthritis suggests a heightened risk of MRSA infection.</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"50 1","pages":"212"},"PeriodicalIF":3.2,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11465504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142400275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Italian Journal of Pediatrics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1